Overcoming methodological weakness in dose-intense alkylating agent studies through pharmacology.
Jones
Roy B
RB
D000477:Alkylating Agents / Q000494:pharmacology*; D002986:Clinical Trials as Topic / Q000379:methods*; D003520:Cyclophosphamide / Q000494:pharmacology; D018572:Disease-Free Survival; D006801:Humans; D008956:Models, Chemical; D009369:Neoplasms / Q000188:drug therapy*; D011355:Prodrugs; D011897:Random Allocation; D012008:Recurrence; D012107:Research Design
D000477:Alkylating Agents; D011355:Prodrugs; D003520:Cyclophosphamide